Saphnelo approved in EU for treatment of moderate to severe

Saphnelo approved in EU for treatment of moderate to severe systemic lupus erythematosus

Saphnelo approved in EU for treatment of moderate to severe systemic lupus erythematosus

miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Canada , Japan , Cambridge , Cambridgeshire , United Kingdom , Netherlands , Amsterdam , Noord Holland , Ronald Van Vollenhoven , Astrazeneca Saphnelo , Company On Twitter Astrazeneca , Astrazeneca , Amsterdam Rheumatology Center , Medarex Inc , European Union , European Commission , Nasdaq , Medicinal Products , Human Use , European Medicines Agency , Executive Vice President , Bristol Myers Squibb , Uncontrolled Lupus , Interferon Pathway , Based Composite Lupus Assessment , New England Journal , Lancet Rheumatology , Rare Diseases ,